<PubmedArticle><MedlineCitation Status="Publisher" Owner="NLM"><PMID Version="1">39377164</PMID><DateRevised><Year>2024</Year><Month>10</Month><Day>08</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1475-097X</ISSN><JournalIssue CitedMedium="Internet"><PubDate><Year>2024</Year><Month>Oct</Month><Day>08</Day></PubDate></JournalIssue><Title>Clinical physiology and functional imaging</Title><ISOAbbreviation>Clin Physiol Funct Imaging</ISOAbbreviation></Journal><ArticleTitle>COVID-19 is associated with cardiac structural and functional remodelling in healthy middle-aged and older individuals.</ArticleTitle><ELocationID EIdType="doi" ValidYN="Y">10.1111/cpf.12909</ELocationID><Abstract><AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">Coronavirus disease 2019 (COVID-19) was declared a global pandemic in 2019. It remains uncertain to what extent COVID-19 effects the heart in heathy individuals. To evaluate the effect of the COVID-19 on cardiac structure and function in middle-aged and older individuals.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">A single-centre prospective observational study enroled a total of 124 participants (84 with history of COVID-19 [COVID-19 group] and 40 without a history of COVID-19 [non-COVID group]). All participants underwent echocardiography with speckle tracking to assess cardiac structure and function at rest and during peak exercise.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">There were no differences in left and right ventricular diastolic function (p ≥ 0.05) between the COVID-19 and non-COVID-19 groups. Participants in COVID-19 group demonstrated higher left ventricular mass (130 ± 39.8 vs. 113 ± 27.2 g, p = 0.008) and relative wall thickness (0.38 ± 0.07 vs. 0.36 ± 0.13, p = 0.049). Left ventricular global longitudinal strain was reduced in the COVID-19 group at rest and at peak-exercise (rest: 18.3 ± 2.01 vs. 19.3 ± 1.53%, p = 0.004; peak exercise: 19.1 ± 2.20 vs. 21.0 ± 1.58%, p ≤ 0.001). However, no difference was seen in resting left ventricular ejection fraction (58 ± 2.89 vs. 59 ± 2.51%, p = 0.565) between groups. Right ventricular fractional area change was reduced in the COVID-19 group (p = 0.012).</AbstractText><AbstractText Label="CONCLUSION" NlmCategory="CONCLUSIONS">Cardiac structural and functional remodelling was observed in middle-aged and older otherwise healthy individuals with a history of COVID-19.</AbstractText><CopyrightInformation>© 2024 The Author(s). Clinical Physiology and Functional Imaging published by John Wiley &amp; Sons Ltd on behalf of Scandinavian Society of Clinical Physiology and Nuclear Medicine.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Rahman</LastName><ForeName>Mushidur</ForeName><Initials>M</Initials><Identifier Source="ORCID">0000-0001-9455-8088</Identifier><AffiliationInfo><Affiliation>Research Centre for Health and Life Sciences, Institute for Health and Wellbeing, Coventry University, Coventry, UK.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Cardiology, University Hospitals Coventry and Warwickshire NHS Trust, Coventry, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Russell</LastName><ForeName>Sophie L</ForeName><Initials>SL</Initials><AffiliationInfo><Affiliation>Research Centre for Health and Life Sciences, Institute for Health and Wellbeing, Coventry University, Coventry, UK.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Cardiology, University Hospitals Coventry and Warwickshire NHS Trust, Coventry, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Okwose</LastName><ForeName>Nduka C</ForeName><Initials>NC</Initials><AffiliationInfo><Affiliation>Research Centre for Health and Life Sciences, Institute for Health and Wellbeing, Coventry University, Coventry, UK.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Cardiology, University Hospitals Coventry and Warwickshire NHS Trust, Coventry, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>McGregor</LastName><ForeName>Gordon</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Department of Cardiology, University Hospitals Coventry and Warwickshire NHS Trust, Coventry, UK.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Research Centre for Healthcare and Community, Institute of Health and Wellbeing, Coventry University, Coventry, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Maddock</LastName><ForeName>Helen</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Research Centre for Health and Life Sciences, Institute for Health and Wellbeing, Coventry University, Coventry, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Banerjee</LastName><ForeName>Prithwish</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Research Centre for Health and Life Sciences, Institute for Health and Wellbeing, Coventry University, Coventry, UK.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Cardiology, University Hospitals Coventry and Warwickshire NHS Trust, Coventry, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Jakovljevic</LastName><ForeName>Djordje G</ForeName><Initials>DG</Initials><AffiliationInfo><Affiliation>Research Centre for Health and Life Sciences, Institute for Health and Wellbeing, Coventry University, Coventry, UK.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Cardiology, University Hospitals Coventry and Warwickshire NHS Trust, Coventry, UK.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><Agency>Coventry University COVID-19 Research</Agency><Country /></Grant><Grant><Agency>Innovation fund for the PhD Studentship</Agency><Country /></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2024</Year><Month>10</Month><Day>08</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Clin Physiol Funct Imaging</MedlineTA><NlmUniqueID>101137604</NlmUniqueID><ISSNLinking>1475-0961</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">COVID‐19</Keyword><Keyword MajorTopicYN="N">cardiac structure and function</Keyword><Keyword MajorTopicYN="N">speckle tracking echocardiography</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="revised"><Year>2024</Year><Month>8</Month><Day>19</Day></PubMedPubDate><PubMedPubDate PubStatus="received"><Year>2024</Year><Month>5</Month><Day>23</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2024</Year><Month>9</Month><Day>25</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>10</Month><Day>8</Day><Hour>7</Hour><Minute>3</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>10</Month><Day>8</Day><Hour>7</Hour><Minute>3</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>10</Month><Day>8</Day><Hour>5</Hour><Minute>24</Minute></PubMedPubDate></History><PublicationStatus>aheadofprint</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">39377164</ArticleId><ArticleId IdType="doi">10.1111/cpf.12909</ArticleId></ArticleIdList><ReferenceList><Title>REFERENCES</Title><Reference><Citation>Benjamin, E.J., D'Agostino, R.B., Belanger, A.J., Wolf, P.A. &amp; Levy, D. (1995) Left atrial size and the risk of stroke and death: the Framingham Heart Study. Circulation, 92, 835–841.</Citation></Reference><Reference><Citation>Bhatia, H.S., Bui, Q.M., King, K., DeMaria, A. &amp; Daniels, L.B. (2021) Subclinical left ventricular dysfunction in COVID‐19. International Journal of Cardiology. Heart &amp; Vasculature, 34, 100770.</Citation></Reference><Reference><Citation>Bleakley, C., Singh, S., Gar, B., Morosin, M., Surkova, E., Mandalia, M. S. et al. (2020) Right ventricular dysfunction in critically ill COVID‐19 ARDs. International Journal of Cardiology, 327, 251–258.</Citation></Reference><Reference><Citation>Chapman, A.R., Bularga, A. &amp; Mills, N.L. (2020) High‐sensitivity cardiac troponin can be an ally in the fight against COVID‐19. Circulation, 141, 1733–1735.</Citation></Reference><Reference><Citation>Chen, L.Q., Burdowski, J., Marfatia, R., Weber, J., Gliganic, K., Diaz, N. et al. (2020) Reduced cardiac function is associated with cardiac injury and mortality risk in hospitalized COVID‐19 patients. Clinical Cardiology, 43, 1547–1554.</Citation></Reference><Reference><Citation>Chen, T., Wu, D., Chen, H., Yan, W., Yang, D., Chen, G. et al. (2020) Clinical characteristics of 113 deceased patients with coronavirus disease 2019: retrospective study. BMJ, 368, m1295.</Citation></Reference><Reference><Citation>D'Ascenzi, F., Pelliccia, A., Natali, B.M., Cameli, M., Andrei, V., Incampo, E. et al. (2015) Increased left atrial size is associated with reduced atrial stiffness and preserved reservoir function in athlete's heart. The International Journal of Cardiovascular Imaging, 31, 699–705. United States.</Citation></Reference><Reference><Citation>Dalla, K., Hallman, C., Bech‐Hanssen, O., Haney, M. &amp; Ricksten, S.E. (2015) Strain echocardiography identifies impaired longitudinal systolic function in patients with septic shock and preserved ejection fraction. Cardiovascular Ultrasound, 13, 30.</Citation></Reference><Reference><Citation>Dobson, R., Ghosh, A.K., Ky, B., Marwick, T., Stout, M., Harkness, A. et al. (2021) British society for echocardiography and British Cardio‐Oncology society guideline for transthoracic echocardiographic assessment of adult cancer patients receiving anthracyclines and/or trastuzumab. Echo Research &amp; Practice, 8, G1–G18.</Citation></Reference><Reference><Citation>Dweck, M.R., Bularga, A., Hahn, R.T., Bing, R., Lee, K.K., Chapman, A.R. et al. (2020) Global evaluation of echocardiography in patients with COVID‐19. European Heart Journal ‐ Cardiovascular Imaging, 21, 949–958.</Citation></Reference><Reference><Citation>Freaney, P.M., Shah, S.J. &amp; Khan, S.S. (2020) COVID‐19 and heart failure with preserved ejection fraction. Journal of the American Medical Association, 324, 1499–1500.</Citation></Reference><Reference><Citation>Garcia‐Zamora, S., Picco, J.M., Lepori, A.J., Galello, M.I., Saad, A.K., Ayón, M. et al. (2023) Abnormal echocardiographic findings after COVID‐19 infection: a multicenter registry. The International Journal of Cardiovascular Imaging, 39, 77–85.</Citation></Reference><Reference><Citation>Günay, N., Demiröz, Ö., Kahyaoğlu, M., Başlılar, Ş., Aydın, M., Özer, M.Ç. et al. (2021) The effect of moderate and severe COVID‐19 pneumonia on short‐term right ventricular functions: a prospective observational single pandemic center analysis. The International Journal of Cardiovascular Imaging, 37, 1883–1890.</Citation></Reference><Reference><Citation>Gutiérrez‐Chico, J.L., Zamorano, J.L., Pérez de Isla, L., Orejas, M., Almería, C., Rodrigo, J.L. et al. (2005) Comparison of left ventricular volumes and ejection fractions measured by three‐dimensional echocardiography versus by two‐dimensional echocardiography and cardiac magnetic resonance in patients with various cardiomyopathies. The American Journal of Cardiology, 95, 809–813.</Citation></Reference><Reference><Citation>Hameed, A., Condliffe, R., Swift, A.J., Alabed, S., Kiely, D.G. &amp; Charalampopoulos, A. (2023) Assessment of right ventricular function—a state of the art. Current Heart Failure Reports, 20(3), 194–207.</Citation></Reference><Reference><Citation>Harkness, A., Ring, L., Augustine, D.X., Oxborough, D., Robinson, S. &amp; Sharma, V. (2020) Normal reference intervals for cardiac dimensions and function for use in echocardiographic practice: a guideline from the British society of echocardiography. Echo Research &amp; Practice, 7, G1–G18.</Citation></Reference><Reference><Citation>Ikonomidis, I., Aboyans, V., Blacher, J., Brodmann, M., Brutsaert, D.L., Chirinos, J.A. et al. (2019) The role of ventricular‐arterial coupling in cardiac disease and heart failure: assessment, clinical implications and therapeutic interventions. A consensus document of the european society of cardiology working group on aorta &amp; peripheral vascular diseases, european association of cardiovascular imaging, and heart failure association. European Journal of Heart Failure, 21, 402–424.</Citation></Reference><Reference><Citation>Ilardi, F., Crisci, M., Calabrese, C., Scognamiglio, A., Arenga, F., Manzo, R. et al. (2023) Effects on right ventricular function one year after COVID‐19‐related pulmonary embolism. Journal of Clinical Medicine, 12, 3611.</Citation></Reference><Reference><Citation>Janus, S.E., Hajjari, J., Karnib, M., Tashtish, N., Al‐Kindi, S.G. &amp; Hoit, B.D. (2020) Prognostic value of left ventricular global longitudinal strain in COVID‐19. The American Journal of Cardiology, 131, 134–136.</Citation></Reference><Reference><Citation>Kamalov, G., Bhattacharya, S.K. &amp; Weber, K.T. (2010) Congestive heart failure: where homeostasis begets dyshomeostasis. Journal of Cardiovascular Pharmacology, 56, 320–328.</Citation></Reference><Reference><Citation>Kerstens, T.P., Donker, S.C., Kleinnibbelink, G., van Dijk, A.P., Oxborough, D. &amp; Thijssen, D. (2024) Left and right ventricular strain‐volume/area loops: a narrative review of current physiological understanding and potential clinical value. Echo Research and Practice, 11(1), 12.</Citation></Reference><Reference><Citation>Lassen, M.C.H., Skaarup, K.G., Lind, J.N., Alhakak, A.S., Sengeløv, M., Nielsen, A.B. et al. (2020) Echocardiographic abnormalities and predictors of mortality in hospitalized COVID‐19 patients: the ECHOVID‐19 study. ESC Heart Failure, 7, 4189–4197.</Citation></Reference><Reference><Citation>Li, B., Yang, J., Zhao, F., Zhi, L., Wang, X., Liu, L. et al. (2020) Prevalence and impact of cardiovascular metabolic diseases on COVID‐19 in China. Clinical research in cardiology, 109, 531–538.</Citation></Reference><Reference><Citation>Li, Q., Guan, X., Wu, P., Wang, X., Zhou, L., Tong, Y. et al. (2020) Early transmission dynamics in Wuhan, China, of novel coronavirus–infected pneumonia. New England Journal of Medicine, 382, 1199–1207.</Citation></Reference><Reference><Citation>Lippi, G. &amp; Plebani, M. (2020) Laboratory abnormalities in patients with COVID‐2019 infection. Clinical Chemistry and Laboratory Medicine, 58, 1131–1134.</Citation></Reference><Reference><Citation>Maslo, C., Friedland, R., Toubkin, M., Laubscher, A., Akaloo, T. &amp; Kama, B. (2022) Characteristics and outcomes of hospitalized patients in South Africa during the COVID‐19 omicron wave compared with previous waves. Journal of the American Medical Association, 327, 583–584.</Citation></Reference><Reference><Citation>Ngiam, J.N., Chew, N.W., Tan, B.Y.Q., Sim, H.W., Kong, W.K.F., Yeo, T.C. et al. (2020) Novel echocardiography‐derived left ventricular stiffness index in Low‐flow versus normal‐flow severe aortic stenosis with preserved left ventricular ejection fraction. Scientific Reports, 10, 9086.</Citation></Reference><Reference><Citation>Oikonomou, E., Lampsas, S., Theofilis, P., Souvaliotis, N., Papamikroulis, G.A., Katsarou, O. et al. (2023) Impaired left ventricular deformation and ventricular‐arterial coupling in post‐COVID‐19: association with autonomic dysregulation. Heart and Vessels, 38, 381–393.</Citation></Reference><Reference><Citation>Oikonomou, E., Souvaliotis, N., Lampsas, S., Siasos, G., Poulakou, G., Theofilis, P. et al. (2022) Endothelial dysfunction in acute and long standing COVID‐19: a prospective cohort study. Vascular Pharmacology, 144, 106975.</Citation></Reference><Reference><Citation>Orru D'Ávila, L.B., Gervazoni Balbuena de Lima, A.C., Milani, M. et al. (2023) Left ventricular global longitudinal strain and cardiorespiratory fitness in patients with heart failure: systematic review and meta‐analysis. Hellenic Journal of Cardiology, 79, 58–69.</Citation></Reference><Reference><Citation>Rahman, M., Russell, S.L., Okwose, N.C., Hood, O.M.A., Harwood, A.E., McGregor, G. et al. (2023) Cardiovascular implications and physical activity in middle‐aged and older adults with a history of COVID‐19 (CV COVID): a protocol for a randomised controlled trial. Trials, 24, 328.</Citation></Reference><Reference><Citation>Raisi‐Estabragh, Z., Cooper, J., Salih, A., Raman, B., Lee, A. M., Neubauer, S. et al. (2022) Cardiovascular disease and mortality sequelae of COVID‐19 in the UK biobank. Heart, 109, 119–126.</Citation></Reference><Reference><Citation>Robinson, S., Rana, B., Oxborough, D., Steeds, R., Monaghan, M., Stout, M. et al. (2020) A practical guideline for performing a comprehensive transthoracic echocardiogram in adults: the British society of echocardiography minimum dataset. Echo Research &amp; Practice, 7, G59–G93.</Citation></Reference><Reference><Citation>Shi, S., Qin, M., Cai, Y., Liu, T., Shen, B., Yang, F. et al. (2020) Characteristics and clinical significance of myocardial injury in patients with severe coronavirus disease 2019. European Heart Journal, 41, 2070–2079.</Citation></Reference><Reference><Citation>Shi, S., Qin, M., Shen, B., Cai, Y., Liu, T., Yang, F. et al. (2020) Association of cardiac injury with mortality in hospitalized patients with COVID‐19 in Wuhan, China. JAMA Cardiology, 5, 802–810.</Citation></Reference><Reference><Citation>Shmueli, H., Shah, M., Ebinger, J.E., Nguyen, L.C., Chernomordik, F., Flint, N. et al. (2021) Left ventricular global longitudinal strain in identifying subclinical myocardial dysfunction among patients hospitalized with COVID‐19. International Journal of Cardiology. Heart &amp; Vasculature, 32, 100719.</Citation></Reference><Reference><Citation>Smiseth, O.A., Torp, H., Opdahl, A., Haugaa, K.H. &amp; Urheim, S. (2016) Myocardial strain imaging: how useful is it in clinical decision making? European Heart Journal, 37, 1196–1207.</Citation></Reference><Reference><Citation>Steeds, R.P., Wheeler, R., Bhattacharyya, S., Reiken, J., Nihoyannopoulos, P., Senior, R. et al. (2019) Stress echocardiography in coronary artery disease: a practical guideline from the British society of echocardiography. Echo Research &amp; Practice, 6, G17–G33.</Citation></Reference><Reference><Citation>Stöbe, S., Richter, S., Seige, M., Stehr, S., Laufs, U. &amp; Hagendorff, A. (2020) Echocardiographic characteristics of patients with SARS‐CoV‐2 infection. Clinical Research in Cardiology, 109, 1549–1566.</Citation></Reference><Reference><Citation>Stockenhuber, A., Vrettos, A., Androschuck, V., George, M., Robertson, C., Bowers, N. et al. (2021) A pilot study on right ventricular longitudinal strain as a predictor of outcome in COVID‐19 patients with evidence of cardiac involvement. Echocardiography, 38, 222–229.</Citation></Reference><Reference><Citation>Støylen, A., Dalen, H. &amp; Molmen, H.E. (2020) Left ventricular longitudinal shortening: relation to stroke volume and ejection fraction in ageing, blood pressure, body size and gender in the HUNT3 study. Open Heart, 7(2), e001243.</Citation></Reference><Reference><Citation>Sugimoto, T., Robinet, S., Dulgheru, R., Bernard, A., Ilardi, F., Contu, L. et al. (2018) Echocardiographic reference ranges for normal left atrial function parameters: results from the EACVI NORRE study. European Heart Journal ‐ Cardiovascular Imaging, 19, 630–638.</Citation></Reference><Reference><Citation>Tavazzi, G., Pellegrini, C., Maurelli, M., Belliato, M., Sciutti, F., Bottazzi, A. et al. (2020) Myocardial localization of coronavirus in COVID‐19 cardiogenic shock. European Journal of Heart Failure, 22, 911–915.</Citation></Reference><Reference><Citation>Tsang, T.S.M., Abhayaratna, W.P., Barnes, M.E., Miyasaka, Y., Gersh, B.J., Bailey, K.R. et al. (2006) Prediction of cardiovascular outcomes with left atrial size. Journal of the American College of Cardiology, 47, 1018–1023.</Citation></Reference><Reference><Citation>Turan, T., Özderya, A., Şahin, S., Konuş, A.H., Kul, S., Akyüz, A.R. et al. (2021) Left ventricular global longitudinal strain in low cardiac risk outpatients who recently recovered from coronavirus disease 2019. The International Journal of Cardiovascular Imaging, 37, 2979–2989.</Citation></Reference><Reference><Citation>Vosko, I., Zirlik, A. &amp; Bugger, H. (2023) Impact of COVID‐19 on cardiovascular disease. Viruses, 15.</Citation></Reference><Reference><Citation>Wu, Z. &amp; McGoogan, J.M. (2020) Characteristics of and important lessons from the coronavirus disease 2019 (COVID‐19) outbreak in China: summary of a report of 72314 cases from the Chinese center for disease control and prevention. Journal of the American Medical Association, 323, 1239–1242.</Citation></Reference><Reference><Citation>Yang, H., Wright, L., Negishi, T., Liu, J. &amp; Marwick, T. H. (2018) Research to practice: assessment of left ventricular global longitudinal strain for surveillance of cancer chemotherapeutic‐related cardiac dysfunction. JACC Cardiovascular Imaging, 11, 1196–1201.</Citation></Reference><Reference><Citation>Young, K.A., Krishna, H., Jain, V., Hamza, I., Scott, C.G., Pellikka, P.A. et al. (2022) Serial left and right ventricular strain analysis in patients recovered from COVID‐19. Journal of the American Society of Echocardiography, 35, 1055–1063.</Citation></Reference><Reference><Citation>Zaidi, A., Knight, D.S., Augustine, D.X., Harkness, A., Oxborough, D., Pearce, K. et al. (2020) Echocardiographic assessment of the right heart in adults: a practical guideline from the British society of echocardiography. Echo Research &amp; Practice, 7, G19–G41.</Citation></Reference><Reference><Citation>Zhang, Y., Sun, W., Wu, C., Zhang, Y., Cui, L., Xie, Y. et al. (2021) Prognostic value of right ventricular ejection fraction assessed by 3D echocardiography in COVID‐19 patients. Frontiers in Cardiovascular Medicine, 8, 1–13.</Citation></Reference><Reference><Citation>Zheng, Y.Y., Ma, Y.T., Zhang, J.Y. &amp; Xie, X. (2020) COVID‐19 and the cardiovascular system. Nature Reviews Cardiology, 17, 259–260.</Citation></Reference><Reference><Citation>Zhou, F., Yu, T., Du, R., Fan, G., Liu, Y., Liu, Z. et al. (2020) Clinical course and risk factors for mortality of adult inpatients with COVID‐19 in Wuhan, China: a retrospective cohort study. The Lancet, 395, 1054–1062.</Citation></Reference></ReferenceList></PubmedData></PubmedArticle>